StreetInsider.com News Articles

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

Mon, 20 Jul 2026 08:00:00 -0400

MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2026 after the market close on Wednesday, July 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13761338

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

Mon, 20 Jul 2026 08:00:00 -0400

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13761338

Form 4 MIMEDX GROUP, INC. For: Jul 02 Filed by: DOUG RICE

Tue, 07 Jul 2026 08:53:00 -0400

si-local-file:///var/storage/secattach/20260707/26739362.html

Form 4 MIMEDX GROUP, INC. For: Jul 02 Filed by: DOUG RICE

Tue, 07 Jul 2026 08:53:00 -0400

si-local-file:///var/storage/secattach/20260707/26739362.html

Form 4 MIMEDX GROUP, INC. For: Jun 24 Filed by: Maersk-Moller Kimberly

Thu, 25 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260625/26692626.html

Form 4 MIMEDX GROUP, INC. For: Jun 24 Filed by: Maersk-Moller Kimberly

Thu, 25 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260625/26692626.html

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Biotech Insider News Commentary — For most of medical history, the human body’s inability to regrow lost tissue has been treated as a limitation to be managed rather than a problem to be solved. When skin, bone, or soft tissue is destroyed by injury,

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Thu, 18 Jun 2026 12:42:37 -0400

Issued on behalf of Conexeu Sciences Inc.

A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in.

Form 8-K MIMEDX GROUP, INC. For: Jun 10

Tue, 16 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260616/26654220.html

Form 8-K MIMEDX GROUP, INC. For: Jun 10

Tue, 16 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260616/26654220.html

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

A new generation of tissue companies is betting that the future of wound care and reconstruction isn't a better patch — it's a material that helps the body regrow itself. One newly public name just took a concrete step toward proving it.

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — For most of medical history, the body's inability to regrow lost tissue has been treated as a fact to be managed rather than a problem to be solved. When skin,

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

Tue, 16 Jun 2026 10:30:00 -0400

Issued on behalf of Conexeu Sciences Inc.